Mycobacterium indicus pranii is a potent immunomodulator for a recombinant vaccine against human chorionic gonadotropin

Journal of Reproductive Immunology

Volumn 91, Issue 1-2, 2011, Pages 24-30

  Purswani, Shilpi ^a   Talwar, G P ^a   Vohra, Richa ^a   Pal, Rahul ^b   Panda, Amulya K ^b   Lohiya, Nirmal K ^c   Gupta, Jagdish C ^a  

^a Talwar Research Foundation   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Adjuvant; Antibody sub classes; Genetic strains of mice

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOMODULATING AGENT; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOCLAVE; C3H MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC STRAIN; IMMUNE RESPONSE; MOUSE; MOUSE STRAIN SJL; MYCOBACTERIUM; MYCOBACTERIUM INDICUS PRANII; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES; CHORIONIC GONADOTROPIN; CLINICAL TRIALS, PHASE II AS TOPIC; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED C3H; MYCOBACTERIUM; VACCINES, SYNTHETIC;

EID: 80052409642     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.06.099     Document Type: Article

References (23)

1. Fishel S.B., Edwards R.G., Evans C.J. Human chorionic gonadotropin secreted by preimplantation embryos cultured in vitro. Science 1984, 223:816-818.
2. Gupta S., Malhotra A.K., Verma K.K., Sharma V.K. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J. Eur. Acad. Dermatol. Venereol. 2008, 22:1089-1093.
3. Gupta A., Geetha N., Mani J., Upadhyay P., Katoch V.M., Natrajan M., Gupta U.D., Bhaskar S. Immunogenicity and protective efficacy of M.w against M.tb in mice immunized with live versus heat-killed Mw by the aerosol or parenteral route. Infect. Immun. 2009, 77:223-231.
4. He L.Z., Ramakrishna V., Connolly J.E., Wang X.T., Smith P.A., Jones C.L., Valkova-Valchanova M., Arunakumari A., Treml J.F., Goldstein J., Wallace P.K., Keler T., Endres M.J. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen human chorionic gonadotropin β. Clin. Cancer Res. 2004, 10:1920-1927.
5. Hotakainen K., Ljungberg B., Paju A., Rasmuson T., Alfthan H., Stenman U.H. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br. J. Cancer 2002, 86:185-189.
6. Iles R.K. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol. Cell. Endocrinol. 2007, 260-262, 264-270.
7. Iles R.K., Persad R., Trivedi M., Sharma K.B., Dickinson A., Smith P., et al. Urinary concentration of human chorionic gonadotropin and its fragments as a prognostic marker in bladder cancer. Br. J. Urol. 1996, 77:61-69.
8. Kharat I., Nair N.S., Dhall K., Sawhney H., Krishna U., Shahani S.M., Banerjee A.K., Roy S., Hingorani V., Singh O., Talwar G.P. Analysis of menstrual records of women immunized with anti-hCG vaccine inducing antibodies partly cross-reactive with hLH. Contraception 1990, 41:293-299.
9. Nash H., Talwar G.P., Segal S., Luukkainen T., Johannson E.D.B., Vasquez J., Coutinho E., Sundaram K. Observation on the antigenicity and clinical effects of a candidate antipregnancy vaccine: B-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil. Steril. 1980, 34:328-335.
10. Nyasulu P.S. The role of adjunctive Mycobacterium w immunotherapy for tuberculosis. J. Exp. Clin. Med. 2010, 2(3):124-129.
11. Pal R., Singh O., Rao L.V., Talwar G.P. Bioneutralization capacity of the antibodies generated in women by the beta subunit of human chorionic gonadotropin (beta hCG) and beta hCG associated with the alpha subunit of ovine luteinizing hormone linked to carriers. Am. J. Reprod. Immunol. 1990, 22:124-126.
12. Patel N., Trapathi S.B. Improved cure rates in pulmonary tuberculosis category II (retreatment) with Mycobacterium w. J. Indian Med. Assoc. 2003, 101:680-682.
13. Purswani S., Talwar G.P. Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin. Vaccine 2011, 29:2341-2348.
14. Rakshit S., Ponnusamy M., Papanna S., Saha B., Ahmed A., Nandi D. Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNγ. Int. J. Cancer 2011, 10.1002/ijc.26099.
15. Saini V., Raghuvanshi S., Talwar G.P., Ahmed N., Khurana J.P., Hasnain S.E., Tyagi A.K., Tyagi A.K. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species. PLoS One 2009, 4(7):e6263.
16. Talwar G.P. An immunotherapeutic vaccine for multibacillary leprosy. Int. Rev. Immunol. 1999, 18:229-249.
17. Talwar G.P., Sharma N.C., Dubey S.K., Salahuddin M., Das C., Ramakrishnan S., Kumar S., Hingorani V. Isoimmunisation against human chorionic gonadotropin with conjugates of processed beta subunit of the hormone and tetanus toxoid. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:218-222.
18. Talwar G.P., et al. 14 Papers in Golden Jubilee Issue Leprosy in India, vol. 50 1978, 492-597.
19. Talwar G.P., Singh O., Rao L.V. An improved immunogen for anti hCG vaccine eliciting antibodies reactive with a conformation native to the hormone without cross reaction with human follicle stimulating hormone. J. Reprod. Immunol. 1988, 14:203-212.
20. Talwar G.P., Hingorani V., Kumar S., Roy S., Banerjee A.K., Shahani S.M., Krishna U., Dhall K., Sawhney H., Sharma N.C., Singh O., Gaur A., Rao L.V., Aruman K. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception 1990, 41:301-316.
21. Talwar G.P., Singh O., Pal R., Chatterjee N., Sahai P., Dhall K., et al. A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8532-8536.
22. Talwar G.P., Vyas H.K., Purswani S., Gupta J.C. Gonadotropin-releasing hormone/human chorionic gonadotropin β based recombinant antibodies and vaccines. J. Reprod. Immunol. 2009, 83:158-163.
23. Talwar G.P., Gupta J.C., Shankar N.V. Immunological approaches against human chorionic gonadotropin for preventing unwanted pregnancy and therapy of advanced stage cancers expressing hCG/subunits. Am. J. Reprod. Immunol. 2011, 66:26-39.